First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Ultralife: the setup is constructive — US defense budget allocations and procurement timing - delays in military program funding or contract awards directly…
★ Analysts see FY2026 revenue reaching $225M — +17.7% growth in a single year.
Why Revenue Could Accelerate
1US defense budget allocations and procurement timing - delays in military program funding or contract awards directly impact quarterly revenue volatility
3Raw material cost inflation - lithium carbonate and cobalt pricing directly impacts gross margins given limited ability to pass through costs on fixed-price contracts
4Foreign military sales (FMS) activity - international defense customers purchasing US military equipment often require Ultralife batteries as integrated components
value - Stock trades at 0.5x P/S and 0.6x P/B with 16.8% FCF yield, attracting deep-value investors betting on defense cycle inflection…
Rising rates create moderate headwinds through two channels: (1) higher discount rates compress valuation multiples for low-growth…
Watch on earnings: US defense discretionary spending trends and continuing resolutions - impacts contract award timing and program funding, Lithium carbonate spot prices (China benchmark) - 6-12 month leading indicator of COGS pressure given procurement lag, Industrial production index - correlates with oil & gas and utility sector demand for ruggedized industrial batteries.
One Sentence Summary:
The bull case: Ultralife is positioned for +17.7% growth on the back of us defense budget allocations and procurement timing - delays in military program funding or contract awards directly.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.